Immediate release pharmaceutical formulation of 4-[3-(4- cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H- phthalazin-1-one | Patent Number 11633396

US 11633396 B2
Application Number17821833
Publication NumberUS 20230000862 A1
Pendency8 months, 4 days
Filled DateAug 24, 2022
Priority DateOct 7, 2008
Publication DateJan 5, 2023
Expiration DateOct 6, 2028
Inventor/ApplicantsBernd Harald Liepold
Claudia Bettina Packhaeuser
Benedikt Steitz
Katja Maren Fastnacht
Kieran James Lennon
Julie Kay Cahill
Michael Karl Bechtold
ExaminesANTHOPOLOS, PETER
Art Unit1611
Technology Center1600
Assignments
Kudos Pharmaceuticals Limited
Current
Kudos Pharmaceuticals LimitedAstrazeneca
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.